China's medical device industry reached a market size of 1.44 trillion yuan (approximately $208 billion) in2025, with exports hitting $50.47 billion — up3.54% year-on-year. The country is no longer just the world's low-cost factory; it is rapidly shifting toward technology-driven, brand-competitive manufacturing. But for international distributors, importers, and healthcare brands, this growth brings a critical challenge: how do you separate the reliable OEM partners from the thousands of factories that claim to be "certified"?

Whether you're sourcing home diagnostic test kits, mesh nebulizers, or point-of-care monitoring devices, this guide walks you through the exact framework MedAsia uses to evaluate manufacturing partners on behalf of our clients.

1. Start With Certifications — But Verify, Don't Just Ask

Certifications are the most objective indicator of a manufacturer's commitment to quality. But here's the problem: many factories display certificate logos on their websites without actually holding current, device-specific approvals.

The non-negotiables:

• ISO13485:2016 — The international standard for medical device QMS. Check that the certificate scope covers your specific product category, not just "medical devices" generically.
• CE Marking under EU MDR2017/745 — The new MDR framework replaced the older MDD and demands clinical evaluation, post-market surveillance, and traceability. For IVD products, look for IVDR compliance.
• FDA510(k) Clearance or Establishment Registration — Required for U.S. market access. Verify the registration number in the FDA's public database. Note: "FDA registered" is not the same as "FDA cleared."
• NMPA Registration (China) — Confirms the factory operates under domestic regulatory oversight, which adds a layer of accountability.

Verification tip: Request the actual certificate PDF, check the expiry date, and confirm the notified body is a legitimate, EU-designated organization. Cross-reference FDA registrations at accessdata.fda.gov.

2. Factory vs. Trading Company: Know the Difference

Quality control inspection at a medical device factory — the kind of access a genuine manufacturer provides

One of the most common pitfalls in China sourcing is working with a trading company that presents itself as a factory. This isn't inherently bad — traders can offer value for small orders — but it becomes a serious problem when compliance documentation is involved.

Factory vs. Trading Company — Key Differences:

At MedAsia, we maintain relationships with 500+ verified factories and conduct on-site audits before recommending any partner. Learn more about our supplier verification process.

3. The5-Phase Due Diligence Protocol

Based on our15+ years of experience in medical device sourcing, here's the evaluation framework we recommend:

Phase1: Pre-Engagement Screening

Validate the business license via China's National Enterprise Credit Information Portal (gsxt.gov.cn). Cross-check FDA establishment registration and EU Authorized Representative status. Confirm ISO13485 scope is product-specific.

Phase2: Technical Capability Audit

Request process flow diagrams for your specific product. Verify cleanroom classification (ISO14644) if applicable. Demand material traceability records and Certificate of Analysis (COA) for critical components.

Phase3: On-Site Production Audit

Inspect the actual production line — not the showroom. Check raw material quarantine areas, in-process QC checkpoints, and calibration logs for metrology equipment. Engage a third-party inspector (SGS, TÜV, QIMA) if you can't visit in person.

Phase4: Supply Chain Mapping

Require a Tier-2 supplier list for critical components. Validate raw material COAs. Audit sub-tier supplier quality agreements. This is especially important for IVD products where reagent quality directly affects test accuracy.

Phase5: Post-Verification Validation

Conduct a3-batch production monitoring run before committing to volume orders. Validate the factory's post-market surveillance system and test their recall protocol.

4. Red Flags That Should Stop You Immediately

• No valid ISO13485 certificate with device-specific scope
• FDA registration number doesn't match the business license
• "Samples" were produced at a different facility than the one being audited
• Refusal to share factory layout or allow ERP system access
• Inconsistent production capacity claims (e.g.,10,000 units/month but no automated lines)

5. MOQ, Pricing, and Lead Time Expectations

Understanding realistic MOQs and timelines helps you filter out factories that aren't a fit for your scale:

• Private-label / white-label runs: MOQ typically starts at500–1,000 units
• Custom tooling / OEM with new molds: MOQ2,000–5,000+ units, lead time60–120 days
• Existing platform private label:500 units, lead time30–65 days
• Certified products command a premium: An FDA-cleared pulse oximeter may cost40–60% more than the identical uncertified version — but that premium protects your business from regulatory liability